Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Total Debt (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Total Debt for 4 consecutive years, with $22.1 million as the latest value for Q2 2019.

  • On a quarterly basis, Total Debt fell 14.8% to $22.1 million in Q2 2019 year-over-year; TTM through Jun 2019 was $22.1 million, a 14.8% decrease, with the full-year FY2018 number at $26.2 million, up 622.79% from a year prior.
  • Total Debt was $22.1 million for Q2 2019 at Forte Biosciences, down from $24.1 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $26.2 million in Q4 2018 to a low of $2.0 million in Q1 2018.
  • A 4-year average of $14.6 million and a median of $10.2 million in 2016 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: tumbled 77.02% in 2018, then surged 1124.09% in 2019.
  • Forte Biosciences' Total Debt stood at $10.2 million in 2016, then crashed by 64.6% to $3.6 million in 2017, then skyrocketed by 622.79% to $26.2 million in 2018, then fell by 15.73% to $22.1 million in 2019.
  • Per Business Quant, the three most recent readings for FBRX's Total Debt are $22.1 million (Q2 2019), $24.1 million (Q1 2019), and $26.2 million (Q4 2018).